| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.5 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |